Related Experiment Video
Updated: Feb 28, 2026

A Semi-high-throughput Imaging Method and Data Visualization Toolkit to Analyze C. elegans Embryonic Development
Published on: October 29, 2019
Prospective Assessment of Embryoid Body by Deep Learning on Label-Free Time-Lapse Images from the Microwell Array
Yoshinori Inoue1, Yoshitaka Miyamoto2, Shuya Suda3
1School of Medical Science, Fujita Health University, Toyoake 470-1192, Japan.
Abstract:
Background: Embryoid bodies (EBs) play a central role in organoid engineering, where their formation fidelity and size critically influence downstream differentiation outcomes. Current EB production workflows primarily rely on retrospective quality assessment, which limits reproducibility in high-throughput culture systems. Objective: This study aimed to develop a prospective, non-invasive framework that integrates early-phase bright-field time-lapse imaging with a three-dimensional convolutional neural network to predict EB formation outcomes and final EB diameter within the microwell platform. Methods: Time-lapse image sequences collected during the first hours after cell seeding on the microwell array were used to train 3D-CNN models for classification (formation vs. non-formation) and regression (final diameter). A balanced dataset was constructed through under-sampling, and five-fold cross-validation with data augmentation was applied to evaluate model performance. Results: The classification model achieved an accuracy of 96.5%, reliably distinguishing between successful and failed EB formation using short-duration image sequences. The regression model predicted the final EB diameter with a mean absolute error of ±7.1 µm, reflecting strong agreement with measured values and capturing seeding-density-dependent size variations. Conclusions: Early aggregation dynamics captured by bright-field time-lapse imaging contain sufficient spatiotemporal information to enable accurate, prospective EB quality prediction. The proposed framework provides a label-free and automation-compatible strategy for improving reproducibility in large-scale EB manufacturing and supports the future development of adaptive and closed-loop organoid culture systems for clinical applications.

